Directors run the work.
Both directors are on the plant floor and personally sign every major MSA. There is no gatekeeper between you and the person accountable.
CapabilitiesSix capabilities.
Six capabilities.
One accountable
QA framework.
Every capability runs on the same SOPs, the same batch-record chain, and the same director sign-off. Engage us at any point in a molecule's life cycle — the hand-offs between capabilities aren't hand-offs, they're page breaks in the same document.
WHO-GMPMHRA alignedcGMPISO 9001ISO 14001ICH Q7ICH Q9ICH Q10ICH Q1B stabilityUSPEPJPWHO-GMPMHRA alignedcGMPISO 9001ISO 14001ICH Q7ICH Q9ICH Q10ICH Q1B stabilityUSPEPJP
The six capabilities
Read the ones that fit your programme.
Each sub-page includes the process infographic, equipment specs, and a representative case with real metrics — plus a one-click deck request.
End-to-end contract manufacturing
CDMO & CMO
Full-service contract development and manufacturing under one QA framework.
- Milestone-based development pricing with per-kg commercial rates
- Client-owned process IP on fee-for-service engagements
- Director sign-off on every MSA and every major batch
Explore capability
GMP-compliant API production
API manufacturing
cGMP API and intermediates production at pilot and commercial scale.
- Multi-step synthesis with catalytic hydrogenation and cryogenic capability
- In-line QC and full analytical release before every shipment
- ICH Q1B stability program included with every campaign
Explore capability
Method development, validation, QC, stability
Analytical testing
Method development to ICH Q2(R2) validation, plus QC release testing and stability studies.
- Full analytical suite (HPLC, GC-MS, LC-MS, NMR, XRPD, DSC/TGA)
- Method development and ICH Q2(R2) validation
- ICH Q1B compliant stability chambers with client-signed data
Explore capability
Literature to validated synthesis
Route scouting
8-14 week engagements that produce 2-3 viable synthetic routes with scorecards.
- Delivers 2-3 scored routes plus a lab-verified proof of concept
- IP-freedom map with patent-landscape analysis and recommended claims strategy
- Comparative scorecard on cost, PMI, safety, IP, and timeline
Explore capability
Lab → pilot → commercial
Technology transfer
Site-to-site and stage-to-stage transfers with signed transfer protocols.
- Client-signed transfer protocol with unambiguous acceptance criteria
- Analytical method co-validation before the first GMP campaign
- PPQ pass rate consistently above industry average
Explore capability
Discovery, process R&D, green chemistry
R&D and innovation
Small-molecule discovery, process R&D, and green-chemistry alternatives on every route.
- Small-molecule discovery, process R&D, and green-chemistry programmes
- 12 permanent PhD chemists with DoE and Lean-Six-Sigma training
- Every route goes through a green-chemistry review before scale-up
Explore capability
Why choose us
The three things buyers cite when they say yes.
One QA framework across all six.
Whether it's route scouting or commercial supply, the same SOPs, deviation processes, and batch-record chain apply. Transfers between capabilities are page breaks, not hand-offs.
Every route reviewed for green chemistry.
Solvent recovery, catalytic alternatives, and PMI reduction are evaluated on every new route before scale-up. Not marketing — a scorecard on each engagement.
Ready to scope work?
A two-line brief is all it takes.
Send a two-line description of what you need. NDAs signed within one business day. You'll be talking to the SME who runs the capability by the second call.